Navigation Links
BioInformatics LLC Webcast – The Life Science Product Manger’s Toolkit
Date:1/30/2013

Arlington, VA (PRWEB) January 30, 2013

BioInformatics LLC will host a free webcast for life science manufacturers and suppliers. The Product Manager’s Toolkit will discuss the various stages of new product development and how to optimize available market research tools in each.

Leading life science instrument companies have overhauled their product innovation processes, incorporating the critical success factors discovered through best practice research, in the form of a Stage-Gate new product development process. According to several independent research studies (i.e. Product Development & Management Association, AMR Research, Booz-Allen Hamilton, etc.) between 70-85% of leading U.S. companies now use Stage-Gate to drive new products to market.

To manage risk, the parallel activities in each stage must be designed to gather vital information - technical, market, financial, operations - in order to drive down the technical and business risks. Each stage costs more than the preceding one, resulting in incremental commitments. As uncertainties decrease, expenditures are allowed to rise and risk is managed.

This webcast will provide insights about market research tools that can optimize each stage of the new product development process while minimizing risk.

In this presentation, life science supplier companies will be able to:

  • Find out when to deploy various market research tools in the new product development cycle.
  • Learn advantages of specific tools in each stage.
  • Identify low-cost options when budget is an obstacle.
  • Learn about a new, low-cost tool that you can use to do a "gut check" to validate or disprove assumptions at any stage of development.

Prepared by BioInformatics LLC exclusively for life science product and marketing managers, this webcast will take place on:

February 6, from 1PM-2PM Eastern Standard Time.
To register for The Product Managers’ Toolkit, click on the following link:

Click here to reserve your seat.

ABOUT BIOINFORMATICS LLC

BioInformatics LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 70,000 life scientists, we have supported more than 500 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10373565.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioInformatics LLC New Market Report – Opportunities for New Players in the Growing Stem Cell Market
2. BioInformatics LLC New Product Launch – RateMyProduct, a Quick Turnaround Product Assessment Tool for Life Science Suppliers
3. Japan Bioinformatics Announces Study on Leading Mapping Tools for DNA Mutation Discovery
4. Global Bioinformatics Industry
5. Amgen Announces Webcast of 2012 Fourth Quarter and Full Year Financial Results
6. Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2012 Financial Results on January 29th
7. Formedix Partners with Perceptive Informatics for Forthcoming Webcast, “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”
8. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on November 14, 2012
9. Palatin Technologies, Inc. To Report Fiscal Year 2013 First Quarter Results; Teleconference and Webcast to be held on November 14, 2012
10. Life Technologies Reschedules Issuance Of Third Quarter 2012 Performance Report And Associated Conference Call And Webcast to Thursday, November 1, 2012 Due To Expected Severe Weather Conditions
11. Palatin Technologies, Inc. To Report Fiscal Year 2012 Fourth Quarter Results; Teleconference and Webcast to be held on September 11, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... 2017 , ... The recent vote by the American Medication Association to align ... to patients and hopefully sheds new light on the way health insurers, governments and ... and founding partner of Texas Fertility Center . , “This designation is ...
(Date:6/27/2017)... ... 27, 2017 , ... According to a recent report from ... not have negative short- or long-term effects on benthic communities. , The ... located at the Puget Sound Naval Shipyard & Intermediate Maintenance Facility in Bremerton, ...
(Date:6/26/2017)... ... June 26, 2017 , ... NDA Partners Chairman Carl ... Product Development R&D at Allergan and CMC expert with more than twenty-five years ... biopharma companies, has joined the firm as an Expert Consultant. , ...
(Date:6/26/2017)... ... June 26, 2017 , ... Two new members were elected to ... June 9, 2017: Jeremy Nowak, President, J Nowak Strategy and Michele Masucci, Ph.D., Vice ... election of Glen N. Gaulton and Kenneth L. Kring, and re-election of David P. ...
Breaking Biology Technology:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
(Date:4/11/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 30.37% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
Breaking Biology News(10 mins):